Company Filing History:
Years Active: 2010-2016
Title: Inventor Spotlight: Nitin Sharad Chandra Pradhan
Introduction
Nitin Sharad Chandra Pradhan is a prominent inventor based in Thane, India. He holds an impressive portfolio with five patents to his name, focusing on innovative pharmaceutical processes and compounds. His contributions to the field of chemistry and drug development have been instrumental in advancing therapeutic applications.
Latest Patents
Among his notable inventions are two recent patents. The first patent covers "Amorphous and crystalline forms of aprepitant and processes for the preparation thereof." This invention features an amorphous form of aprepitant, along with a process for its preparation. Additionally, it discloses mixtures of polymorph Forms I and II of aprepitant and methods for their creation.
The second significant patent details the "Process for the preparation of strontium ranelate." This innovative process involves reacting a tetraester compound in the presence of a lithium base and an inorganic acid salt of strontium, resulting in the formation of strontium ranelate or its hydrate.
Career Highlights
Nitin has gained substantial experience working with reputable companies such as Glenmark Generics Limited and Glenmark Pharmaceuticals Limited. His tenure at these organizations has allowed him to pursue cutting-edge research and development in the pharmaceutical industry, contributing to the advancement of new medications.
Collaborations
Throughout his career, Nitin has collaborated with skilled professionals, including colleagues like Mangesh Shivram Sawant and Sukumar Sinha. These collaborations have fostered a dynamic environment for the development of innovative solutions and advanced drug formulations.
Conclusion
Nitin Sharad Chandra Pradhan's contributions to the field of pharmaceutical sciences through his patents exemplify his commitment to innovation and excellence. With a focus on developing new processes and forms of crucial medications, he continues to play a significant role in shaping the future of drug development and therapeutic solutions.